Hormone Replacement Therapy Market Size to hit $46.5 billion by 2027, Top Prominent Players: Merck KGaA, Novartis International AG

Increase in worldwide menopausal cases coupled with rise in awareness about post-menopausal signs and the available treatment options among women is expected to notably contribute toward the growth of the global market over next few years.

The global hormone replacement therapy industry was estimated at $31.06 billion in 2019, and is anticipated to hit $46.50 billion by 2027, registering a CAGR of 5.1% from 2020 to 2027.

Download Detailed COVID-19 Impact Sample Report at @ https://www.alliedmarketresearch.com/request-for-customization/9873?reqfor=covid

Covid-19 scenario-
• Fertility treatment, post menopause, has been affected during the pandemic, due to the evidence suggesting that falling estrogen levels could leave older women at heightened risk from the disease and the possibility that hormone withdrawal may speed up the progression of the virus in body. This factor has impacted the global hormone replacement therapy market negatively.
• Also, implementation of lockdown, during the initial phase, has also been detrimental to the growth of the market.
• However, things have started getting normalized yet again and the market is anticipated to revive soon.

Drivers, restraints, and opportunities-

Rise in prevalence of menopausal disorder, increasing awareness about post-menopausal issues among women, and new launches of hormone replacement therapy fuel the growth of the global hormone replacement therapy market. On the other hand, certain adverse effects of hormone replacement therapy and high cost of treatment impede the growth to some extent. However, emergence of telemedicine for hormone replacement therapy is expected to pave the way for lucrative opportunities in the industry.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/9873

The estrogen hormone replacement therapy segment to dominate by 2027-

Based on therapy type, the estrogen hormone replacement therapy segment contributed to more than two-fifths of the global hormone replacement therapy market share in 2019, and is expected to rule the roost by the end of 2027, owing to rise in use of estradiol products in women during post-menopause. The human growth hormone replacement therapy segment, on the other hand, would register the fastest CAGR of 7.1% during the forecast period.

North America garnered the major share in 2019-

Based on region, North America held the major share in 2019, garnering more than two-fifths of the global hormone replacement therapy market, due to increasing launches of generic products of hormone replacement therapy by manufacturers, growth in target population, innovations in the drug delivery systems, and development of new formulations. Simultaneously, the region across Asia-Pacific would exhibit the fastest CAGR of 7.1% from 2020 to 2027. This is attributed to growing awareness about hormone replacement therapy, rising prevalence of diabetes population, and increasing focus of healthcare providers on reducing hormonal deficiencies in China, India, and Japan.

To know more about the report, visit the website at @ https://www.alliedmarketresearch.com/hormone-replacement-therapy-market-A09508

The Major Key Players Are:

Abbott Laboratories, Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd. (Genentech, Inc.), Hisamitsu Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.), Merck KGaA, Mylan N.V. (Viatris Inc.), Novartis International AG, Novo Nordisk A/S, and Pfizer Inc.

Similar Reports:

Antidepressant Drugs Market : https://www.pharmiweb.com/press-release/2021-02-15/antidepressant-drugs-market-size-is-generating-revenue-of-1598-billion-by-2023

Transcriptomics Market : https://www.pharmiweb.com/press-release/2021-02-15/transcriptomics-market-value-to-grasp-79-billion-by-2023-at-cagr-of-138-amr

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:

Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.

This release was published on openPR.